Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In a 1:4 case-control matched analysis of data from a nationwide population-based cohort in South Korea, we evaluated whether metformin use mitigates the risk of nontuberculous mycobacterial disease in patients with type 2 diabetes. Multivariable analysis revealed no significant association of metformin use with a diminished risk for incident nontuberculous mycobacterial disease in patients with type 2 diabetes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269046PMC
http://dx.doi.org/10.1128/aac.01675-22DOI Listing

Publication Analysis

Top Keywords

nontuberculous mycobacterial
12
mycobacterial disease
12
type diabetes
12
population-based cohort
8
south korea
8
disease patients
8
patients type
8
stratification nontuberculous
4
disease risk
4
risk type
4

Similar Publications

Objectives: Disseminated nontuberculous mycobacterial disease (dNTMd) remains a rare but serious complication in people living with HIV (PLWH). This study aimed to assess whether dNTMd independently contributes to delayed CD4-cell recovery following antiretroviral therapy (ART) initiation.

Methods: This retrospective 1:3 single center case-control study analyzed patient data from 2004 to 2023.

View Article and Find Full Text PDF

A 79-year-old female diagnosed with myelodysplastic syndrome (MDS) and germline GATA2 mutation, on compassionate cobimetinib, was admitted with subacute cough and dyspnea. Chest imaging demonstrated a new, large, left hilar mass and consolidation with scattered diffuse mediastinal, supraclavicular, and hilar lymphadenopathy. A core biopsy of the right supraclavicular lymph node was performed.

View Article and Find Full Text PDF

Introduction: Nontuberculous mycobacteria (NTM) are environmental pathogens found in soil, water, and various environments, causing chronic pulmonary infections. They are resistant to chlorine and extreme temperatures but not typically transmissible. NTM infections are often misdiagnosed as tuberculosis (TB), especially in Ethiopia, where data on prevalence is scarce.

View Article and Find Full Text PDF

Objective: This study aimed to establish a multiplex molecular point-of-care assay called incorporating an ultra-fast sample pre-treatment for direct identification of complex (MTBC) and 8 non-tuberculous Mycobacteria (NTM) commonly prioritized in clinical settings, and to evaluate its performance in 149 clinical confirmed mycobacterial-positive samples.

Methods: The study was divided into two stages: a pilot study to establish the methodology and a clinical validation study to evaluate its performance. In the pilot study, we established the and analyzed its performance regarding limits of detection, reproducibility, specificity and efficiency.

View Article and Find Full Text PDF

Mycobacterium hainanense sp. nov. represents an emerging nontuberculous Mycobacterium associated with chronic pulmonary disease.

Sci Rep

August 2025

NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, 3 Xueyuan Road, Haikou, 570102, Hainan, China.

Nontuberculous mycobacteria (NTM) are increasingly recognized as important opportunistic pathogens, particularly in immunocompromised individuals. We discovered a newly identified NTM, initially misidentified as Mycobacterium paraffinicum, isolated from a 42-year-old female with an eight-year history of persistent pulmonary infection. The pathogen shares high molecular similarities with Mycobacterium paraffinicum, Mycobacterium nebraskense, and Mycobacterium scrofulaceum, exhibiting atypical acid-fast properties and slow growth.

View Article and Find Full Text PDF